Regulatory News Item

RNS Number : 1763T
Smiths Group PLC
13 November 2019




News Release

London, 13 November 2019

For immediate release



Smiths Group Q1 Trading Statement

Smiths Group plc ("Smiths" or "the Group") today announces that management expectations for the full year remain unchanged, based on its first quarter performance.

Revenue for the three months ended 31 October for Continuing Operations1 was up 11% on an underlying2 basis. This reflected:

·      Continued good growth in John Crane in both original equipment and aftermarket.

·      Strong growth in Smiths Detection, helped by previously announced contract wins and a low comparator.

·      Organic growth in Flex-Tek from both aerospace and industrial applications.

·      Expected performance at Smiths Interconnect, including the impact of a slowdown in the semiconductor market.

For the full year, the Group expects year on year growth to be weighted towards the first half and to result in a more even balance in overall performance between the first and second halves of the year. 

Revenue for the three months ended 31 October for Smiths Medical, recorded as Discontinued Operations, was up 2% on an underlying2 basis. The previously announced planned separation of Smiths Medical is progressing well and is on track to be completed by the end of H1 CY2020.

In October 2019, Smiths Interconnect completed the acquisition of Reflex Photonics ("Reflex") for an enterprise value of CAD$40m. Reflex's technological leadership in ruggedized fibre optics is critical to demanding applications in defence, space, aerospace and industrial market segments.



1 Continuing Operations exclude Smiths Medical which is accounted for as 'Discontinued Operations - businesses held for    distribution to owners', given the intended separation of Smiths Medical by the end of the first half of CY2020.

2 Underlying modifies headline performance to adjust prior year to reflect an equivalent period of ownership for divested businesses and excludes the effects of foreign exchange, acquisitions and supplemental sales for divested businesses.








Investor enquiries

Media enquiries

Marion Le Bot, Smiths Group
+44 (0)20 7004 1672
+44 (0)75 8315 4386


Deborah Scott, FTI Consulting
+44 (0)20 3727 1459
+44 (0)797 953 7449


Alex Le May, FTI Consulting
+44 (0)20 3727 1308
+44 (0)7702 443 312



Legal Entity Identifier (LEI): 213800MJL6IPZS3ASA11

About Smiths Group

Smiths is a global technology company listed on the London Stock Exchange (SMIN) and operates a sponsored level one ADR programme (SMGZY). Its businesses share common characteristics (well-positioned in growing markets, technology-led, asset-light, digitising, with a high proportion of aftermarket revenues) and a common operating model (The Smiths Excellence System). For more information visit

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact or visit